COMMODORE CAPITAL LP, Ten Percent Owner at Satsuma Pharmaceuticals, holds 4.40M shares in Vera Therapeutics (Ticker: VERA), holds 1.57M shares in VistaGen Therapeutics (Ticker: VTGN), holds 1.45M shares in Enliven Therapeutics (Ticker: ELVN). Most recently, COMMODORE CAPITAL LP Sold ― shares of Vera Therapeutics on Jan 12, 2024 for an estimated value of 18.90M.
What is the percentage of profitable transactions made by COMMODORE CAPITAL LP?
The percentage of profitable transactions made by COMMODORE CAPITAL LP is 13%.
What is the average return per transaction made by COMMODORE CAPITAL LP?
The average return per transaction made by COMMODORE CAPITAL LP is -34.30%.
What stocks does COMMODORE CAPITAL LP hold?
COMMODORE CAPITAL LP holds: STSA, ELVN, VERA, VTGN stocks.
What was COMMODORE CAPITAL LP’s latest transaction?
COMMODORE CAPITAL LP latest transaction was an Informative Sell of $18.90M.
What was COMMODORE CAPITAL LP's most profitable transaction?
COMMODORE CAPITAL LP’s most profitable transaction was an Informative Buy of VERA stock on June 22, 2023. The return on the trade was 20.30%.
What is COMMODORE CAPITAL LP's role in Satsuma Pharmaceuticals?
COMMODORE CAPITAL LP's role in Satsuma Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.